They don't post their agenda or minutes but do usually have their report out with recommendations for approval approximately 10 days after the meetings conclude.(This gives their members enough time to load up on the company stocks, just kidding, maybe.)By most calculations SGEN Adcetris very may well have come up for discussion. If not now, soon. May have a European approval recommendation by next week.
You may be right but I thought they come up before the COMP comitee. Orphan medicinal products which met on the 12th and 13th. I may be mistaken but I thought Adcetris was filed for Orphan drug designation.